Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04784286 · ClinicalTrials.gov registry record · NA

Telemedicine Follow-up for Bariatric Surgery Patients: What Do Patients Prefer

A NA study, sponsored by Mayo Clinic.

Terminated
Registry status
NA
Development phase
24
Enrollment target

NCT04784286: Clinical Trial NA study, sponsored by Mayo Clinic.

NCT04784286 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT04784286, a NA study, was terminated before completion, sponsored by Mayo Clinic.

TERMINATED
Registry status
NA
Development phase
24 participants
Enrollment target

Study Summary

This is a randomized clinical trial that will randomize bariatric patients undergoing laparoscopic sleeve gastrectomy or laparoscopic Roux-en-Y gastric bypass to receive either in-person or telemedicine post-operative follow-up within 30 days after surgery.

Primary Outcome

This will be addressed by asking the following question in the survey: How likely or unlikely would you be to accept an invitation to meet with your bariatric provider via video call from your home when you do not need new labs/imaging, your physician can review outside labs/imaging, and no physical exam/procedure is needed?

Interventions

  • OTHER Telemedicine 30-day post-op visit
  • OTHER In-Person 30-day post-op visit

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2019-05-14
Est. Completion 2020-10-26
Phase NA
Mayo Clinic

2,844 total trials

Why NCT04784286 stopped before completion

NCT04784286 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Telemedicine 30-day post-op visit is the first listed.

NCT04784286 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04784286 about?

NCT04784286 is a clinical study titled "Telemedicine Follow-up for Bariatric Surgery Patients: What Do Patients Prefer". This is a randomized clinical trial that will randomize bariatric patients undergoing laparoscopic sleeve gastrectomy or laparoscopic Roux-en-Y gastric bypass to receive either in-person or telemedicine post-operative follow-up within 30 days after surgery.

What is the current status of trial NCT04784286?

This trial is currently terminated. It is a NA study. The enrollment target is 24 participants. The study started on 2019-05-14. Estimated completion is 2020-10-26.

What interventions are being tested in trial NCT04784286?

The interventions under investigation include: Telemedicine 30-day post-op visit (OTHER), In-Person 30-day post-op visit (OTHER).

Who is sponsoring clinical trial NCT04784286?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04784286's enrollment target sits among peer trials

24 1736th of 2000 higher than 246 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04784286, the US trial registry maintained by the National Library of Medicine. NCT04784286 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.